SALVATICI, ELISABETTA
SALVATICI, ELISABETTA
Universita' degli Studi di MILANO
A new diagnosis of infantile form of alexander disease with a novel DNA mutation of the glial fibrillary acid protein gene (GFAP)
2011-08-01 E. Salvatici, R. Selmi, F. Salvini, E. Riva
Absence of severe recurrent infections in GSD IB
2008-09-01 S. Paci, M. Gasparri, I. Giulini Neri, G. Cagnoli, E. Salvatici, M. Giovannini
Alexander disease infantile form presenting with GFAP gene DNA mutation in exon 1 with substitution missense c.715C>T in p.R239C : a case report
2013-02-01 E. Salvatici, S. Barberi, F. Salvini, R. Selmi, V. Rovelli, E. Riva
Amino acid status 6 hours after the assumption of two amino acid preparations in PKU patients on diet-therapy
2007-08-01 M. Giovannini, D. Casero, S. Paci, M. Gasparri, S. El Oksha, M. Bonza, A.M. Lammardo, E. Salvatici, C. Agostoni
Body composition in schoolchildren in Milan, Italy
2009-10-01 M. Giovannini, M. Sala, F. Cetta, M. Bonza, M. Salvioni, M. Mandelli, E. Salvatici, S. Scaglioni
Bone mass density and body composition measured with dexa in patient affected by hyperphenilalaninemia
2009-10-01 M. Giovannini, M. Bonza, S. Paci, D. Bertolotti, G. Cagnoli, E. Salvatici, E. Riva
Bone metabolism and hypovitaminosis D in patients affected by glycogen storage disease type I (GSD I)
2011-08-01 E. Riva, S. Pieretti, S. Paci, I. Giulini Neri, E. Salvatici, M. Giovannini
Bone mineral density (BMD) in patients affected by hyperphenylalanynemia (HPA) : effects of calcium integration and physical activity evaluated with dual energy x-ray absorptiometry (DEXA)
2011-08-01 E. Riva, E. Salvatici, V. Scelsa, G. Cagnoli, S. Vincenti, S. Paci, M. Giovannini
Bone mineralization in type 1 glycogen storage disease: a two years follow up study
2010-09-01 E. Riva, I. Giulini Neri, M. Gasparri, J. Scotti Gerber, E. Salvatici, D. Minghetti, G. Cagnoli, S. Paci
Breastfeeding in phenylketonuric (PKU) and hyperphenylalaninemic (HPA) infants : how and why
2012-09-01 M. Giovannini, S. Paci, A. Lops, E. Salvatici, E. Verduci, G. Banderali, E. Riva
Breastfeeding in phenylketonuric and hyperphenylalaninemic infants : how and why
2012-09-01 M. Giovannini, S. Paci, A. Lops, E. Salvatici, E. Verduci, G. Banderali, E. Riva
Cardiovascular disease (CVD) risk factors in a population of hypercholesterolemic children with genetic diagnosis of heterozgous familial hypercholesterolemia (HEFH)
2013-01-01 M. Giovannini, C. Pederiva, M.E. Capra, P.C. Poli, S. Barberi, F. Salvini, E. Riva, E. Salvatici
Cardiovascular risk factors in hyperphenylalaninemic children on dietary treatment : correlation between carotid intima-media thickness and docosaexahenoic acid supplementation
2013-01-01 E. Salvatici, C. Pederiva, M.E. Capra, S. Vincenti, S. Paci, M. Giovannini
Case report: GSD type 1. and pregnancy
2008-09-01 S. Paci, M. Gasparri, I. Giulini Neri, M. Bonza, E. Salvatici, M. Giovannini
Cerumen : a fundamental but neglected problem by pediatricians
2016-08-01 P. Marchisio, C. Pipolo, M. Landi, D. Consonni, N. Mansi, G. Di Mauro, E. Salvatici, P. Di Pietro, S. Esposito, G. Felisati, N. Principi
Could neurological symptomatology precede an acute metabolic crisis in patient affected by propionic aciduria (PA)? A particular case report
2012-09-01 S. Paci, S. Vincenti, R. Selmi, E. Salvatici, E. Riva
Densità minerale ossea (BMD) nei pazienti affetti da iperfenilalaninemia (HPA): ruolo della supplementazione con calcio e dell'attività fisica
2011-10-01 E. Riva, E. Salvatici, S. Paci, V. Scelsa, S. Vincenti, M. Giovannini
Diagnosticare la malattia di Fabry per curarla
2008-11-01 E. Salvatici, M. Bonza, S. Bellini, S. Paci, E. Riva
Dietary glycemic index, glycemic load and metabolic profile in children with phenylketonuria
2017-02-01 F. Moretti, N. Pellegrini, E. Salvatici, V. Rovelli, G. Banderali, G. Radaelli, F. Scazzina, M. Giovannini, E. Verduci
Docosahexaenoic acid through childhood: functional role, metabolic association and therapeutic effects
2009-10-07 M. Giovannini, E. Verduci, S. Paci, G. Cagnoli, S. Decarlis, E. Salvatici, C. Agostoni